Trial Details

UNKNOWN
Basic Information
Clinical ID c3005
Identifier NCT02651740
Trial Title Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: Rifaximin|PROCEDURE: Fecal microbiota transplantation
Participant Information
Sponsor Shanghai Zhongshan Hospital
City Shanghai
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2016-04
Primary Completion Date 2023-07
Completion Date 2023-12